member FR940104-2-00031 1 297
of FR940104-2-00031 1 298
the FR940104-2-00031 4 299 305 324 358
public FR940104-2-00031 1 300
wishing FR940104-2-00031 1 301
further FR940104-2-00031 1 302
information FR940104-2-00031 1 303
concerning FR940104-2-00031 1 304
meeting FR940104-2-00031 2 306 359
or FR940104-2-00031 1 307
who FR940104-2-00031 1 308
wishes FR940104-2-00031 1 309
to FR940104-2-00031 1 310
submit FR940104-2-00031 1 311
comments FR940104-2-00031 1 312
should FR940104-2-00031 1 313
contact FR940104-2-00031 1 314
dr. FR940104-2-00031 1 315
donald FR940104-2-00031 2 316 365
g. FR940104-2-00031 2 317 366
barnes FR940104-2-00031 2 318 367
, FR940104-2-00031 7 319 330 335 347 363 368 371
designated FR940104-2-00031 1 320
federal FR940104-2-00031 1 321
official FR940104-2-00031 1 322
for FR940104-2-00031 1 323
executive FR940104-2-00031 1 325
committee FR940104-2-00031 1 326
( FR940104-2-00031 1 327
a101 FR940104-2-00031 1 328
) FR940104-2-00031 1 329
us FR940104-2-00031 1 331
environmental FR940104-2-00031 1 332
protection FR940104-2-00031 1 333
agency FR940104-2-00031 1 334
washington FR940104-2-00031 1 336
dc FR940104-2-00031 1 337
20460 FR940104-2-00031 1 338
at FR940104-2-00031 2 339 357
2022604126 FR940104-2-00031 1 340
; FR940104-2-00031 3 341 344 383
fax FR940104-2-00031 1 342
2022609232 FR940104-2-00031 1 343
and FR940104-2-00031 1 345
internet FR940104-2-00031 1 346
@ FR940104-2-00031 1 348
in FR940104-2-00031 1 349
. FR940104-2-00031 5 350 360 364 375 379
limited FR940104-2-00031 1 351
unreserved FR940104-2-00031 1 352
seating FR940104-2-00031 1 353
will FR940104-2-00031 1 354
be FR940104-2-00031 1 355
available FR940104-2-00031 1 356
dated FR940104-2-00031 1 361
: FR940104-2-00031 1 362
staff FR940104-2-00031 1 369
director FR940104-2-00031 1 370
science FR940104-2-00031 1 372
advisory FR940104-2-00031 1 373
board FR940104-2-00031 1 374
[ FR940104-2-00031 1 376
fr FR940104-2-00031 1 377
doc FR940104-2-00031 1 378
9459 FR940104-2-00031 1 380
filed FR940104-2-00031 1 381
1394 FR940104-2-00031 1 382
8:45 FR940104-2-00031 1 384
am FR940104-2-00031 1 385
] FR940104-2-00031 1 386
billing FR940104-2-00031 1 387
code FR940104-2-00031 1 388
656050p FR940104-2-00031 1 389
department FR940104-2-00032 10 0 6 31 44 81 92 275 328 388 407
of FR940104-2-00032 23 1 7 10 24 32 45 71 82 93 105 109 129 146 178 190 198 213 263 276 329 374 389 408
health FR940104-2-00032 10 2 29 33 83 133 267 271 277 385 390
and FR940104-2-00032 19 3 11 34 38 40 67 84 90 107 115 131 139 149 180 226 266 278 391 402
human FR940104-2-00032 6 4 35 85 279 322 392
services FR940104-2-00032 7 5 36 42 86 280 393 404
agriculture FR940104-2-00032 5 8 46 94 330 409
establishment FR940104-2-00032 2 9 101
invitation FR940104-2-00032 2 12 55
for FR940104-2-00032 12 13 15 28 56 118 137 170 210 238 367 384 400
nominations FR940104-2-00032 6 14 57 117 209 223 351
the FR940104-2-00032 23 16 25 63 80 91 100 103 110 119 122 126 144 163 176 183 196 206 219 228 233 256 316 364
dietary FR940104-2-00032 6 17 50 111 135 257 317
guidelines FR940104-2-00032 6 18 51 112 136 258 318
advisory FR940104-2-00032 5 19 52 113 259 319
committee FR940104-2-00032 10 20 53 114 120 123 164 184 211 260 320
agencies FR940104-2-00032 1 21
: FR940104-2-00032 7 22 49 54 60 134 242 350
office FR940104-2-00032 2 23 262
assistant FR940104-2-00032 3 26 382 398
secretary FR940104-2-00032 5 27 252 312 383 399
, FR940104-2-00032 35 30 37 43 79 98 142 152 162 201 246 248 250 261 269 273 281 286 290 292 294 297 306 308 310 321 326 331 334 338 340 343 381 386 397 405
food FR940104-2-00032 2 39 401
consumer FR940104-2-00032 2 41 403
. FR940104-2-00032 14 47 58 75 121 159 182 205 222 237 348 377 394 410 414
action FR940104-2-00032 1 48
summary FR940104-2-00032 1 59
pursuant FR940104-2-00032 1 61
to FR940104-2-00032 8 62 167 175 216 255 315 356 369
national FR940104-2-00032 1 64
nutrition FR940104-2-00032 3 65 130 323
monitoring FR940104-2-00032 1 66
related FR940104-2-00032 1 68
research FR940104-2-00032 1 69
act FR940104-2-00032 1 70
1990 FR940104-2-00032 2 72 127
( FR940104-2-00032 5 73 87 95 298 344
pub FR940104-2-00032 1 74
l. FR940104-2-00032 1 76
101445 FR940104-2-00032 1 77
) FR940104-2-00032 5 78 89 97 300 346
hhs FR940104-2-00032 4 88 106 179 254
usda FR940104-2-00032 4 96 108 181 314
announce FR940104-2-00032 1 99
by FR940104-2-00032 1 102
secretaries FR940104-2-00032 2 104 177
invite FR940104-2-00032 2 116 208
shall FR940104-2-00032 2 124 185
review FR940104-2-00032 1 125
edition FR940104-2-00032 1 128
your FR940104-2-00032 1 132
americans FR940104-2-00032 1 138
determine FR940104-2-00032 1 140
if FR940104-2-00032 2 141 160
on FR940104-2-00032 1 143
basis FR940104-2-00032 1 145
current FR940104-2-00032 1 147
scientific FR940104-2-00032 1 148
medical FR940104-2-00032 1 150
knowledge FR940104-2-00032 1 151
revision FR940104-2-00032 1 153
is FR940104-2-00032 2 154 203
warranted FR940104-2-00032 1 155
at FR940104-2-00032 3 156 195 363
this FR940104-2-00032 2 157 375
time FR940104-2-00032 1 158
so FR940104-2-00032 1 161
will FR940104-2-00032 1 165
proceed FR940104-2-00032 1 166
develop FR940104-2-00032 1 168
recommendations FR940104-2-00032 1 169
revisions FR940104-2-00032 1 171
in FR940104-2-00032 2 172 232
a FR940104-2-00032 1 173
report FR940104-2-00032 2 174 193
be FR940104-2-00032 2 186 353
terminated FR940104-2-00032 1 187
upon FR940104-2-00032 1 188
delivery FR940104-2-00032 1 189
its FR940104-2-00032 1 191
final FR940104-2-00032 1 192
or FR940104-2-00032 3 194 303 360
end FR940104-2-00032 1 197
two FR940104-2-00032 1 199
years FR940104-2-00032 1 200
whichever FR940104-2-00032 1 202
first FR940104-2-00032 1 204
departments FR940104-2-00032 1 207
membership FR940104-2-00032 1 212
individuals FR940104-2-00032 1 214
qualified FR940104-2-00032 1 215
carry FR940104-2-00032 1 217
out FR940104-2-00032 1 218
abovementioned FR940104-2-00032 1 220
tasks FR940104-2-00032 1 221
should FR940104-2-00032 1 224
describe FR940104-2-00032 1 225
document FR940104-2-00032 1 227
nominee FR940104-2-00032 1 229
's FR940104-2-00032 1 230
qualifications FR940104-2-00032 1 231
relevant FR940104-2-00032 1 234
subject FR940104-2-00032 1 235
areas FR940104-2-00032 1 236
further FR940104-2-00032 1 239
information FR940104-2-00032 2 240 324
contact FR940104-2-00032 1 241
elena FR940104-2-00032 2 243 357
t. FR940104-2-00032 2 244 358
carbone FR940104-2-00032 2 245 359
ms FR940104-2-00032 2 247 307
rd FR940104-2-00032 1 249
coe FR940104-2-00032 2 251 311
from FR940104-2-00032 2 253 313
disease FR940104-2-00032 1 264
prevention FR940104-2-00032 1 265
promotion FR940104-2-00032 1 268
public FR940104-2-00032 1 270
service FR940104-2-00032 2 272 325
us FR940104-2-00032 4 274 327 387 406
room FR940104-2-00032 2 282 332
2132 FR940104-2-00032 1 283
switzer FR940104-2-00032 1 284
building FR940104-2-00032 1 285
330 FR940104-2-00032 1 287
c FR940104-2-00032 1 288
street FR940104-2-00032 1 289
sw. FR940104-2-00032 1 291
washington FR940104-2-00032 1 293
dc FR940104-2-00032 1 295
20201 FR940104-2-00032 1 296
202 FR940104-2-00032 1 299
2059007 FR940104-2-00032 1 301
; FR940104-2-00032 2 302 418
debra FR940104-2-00032 2 304 361
reed FR940104-2-00032 2 305 362
ln FR940104-2-00032 1 309
366 FR940104-2-00032 1 333
6505 FR940104-2-00032 1 335
belcrest FR940104-2-00032 1 336
road FR940104-2-00032 1 337
hyattsville FR940104-2-00032 1 339
maryland FR940104-2-00032 1 341
20782 FR940104-2-00032 1 342
301 FR940104-2-00032 1 345
4368457 FR940104-2-00032 1 347
addresses FR940104-2-00032 2 349 365
may FR940104-2-00032 1 352
submitted FR940104-2-00032 1 354
either FR940104-2-00032 1 355
above FR940104-2-00032 1 366
up FR940104-2-00032 1 368
15 FR940104-2-00032 1 370
days FR940104-2-00032 1 371
after FR940104-2-00032 1 372
publication FR940104-2-00032 1 373
notice FR940104-2-00032 1 376
philip FR940104-2-00032 1 378
r. FR940104-2-00032 1 379
lee FR940104-2-00032 1 380
ellen FR940104-2-00032 1 395
haas FR940104-2-00032 1 396
[ FR940104-2-00032 1 411
fr FR940104-2-00032 1 412
doc FR940104-2-00032 1 413
9442 FR940104-2-00032 1 415
filed FR940104-2-00032 1 416
1394 FR940104-2-00032 1 417
8:45 FR940104-2-00032 1 419
am FR940104-2-00032 1 420
] FR940104-2-00032 1 421
billing FR940104-2-00032 1 422
code FR940104-2-00032 1 423
416017m FR940104-2-00032 1 424
food FR940104-2-00033 7 0 25 39 123 158 244 682
and FR940104-2-00033 29 1 26 40 55 85 109 124 159 181 194 199 302 329 354 388 442 506 531 534 562 576 600 686 853 919 1011 1037 1054 1067
drug FR940104-2-00033 17 2 27 41 125 160 178 198 234 238 309 326 352 363 433 684 705 751
administration FR940104-2-00033 5 3 28 42 126 161
[ FR940104-2-00033 2 4 1090
docket FR940104-2-00033 2 5 1041
no FR940104-2-00033 2 6 521
. FR940104-2-00033 50 7 31 35 67 104 129 140 173 190 206 263 287 306 336 365 460 477 498 522 551 594 613 629 655 668 693 712 736 738 764 790 804 806 815 830 847 870 887 924 957 974 979 992 996 1009 1052 1074 1078 1089 1093
93e0353 FR940104-2-00033 1 8
] FR940104-2-00033 2 9 1100
determination FR940104-2-00033 6 10 62 72 421 832 941
of FR940104-2-00033 37 11 17 60 74 77 83 89 95 151 186 221 281 293 296 324 345 370 381 386 422 425 438 495 580 591 630 641 658 679 733 756 833 843 863 883 893 1049
regulatory FR940104-2-00033 13 12 49 254 271 289 372 427 573 610 620 643 835 954
review FR940104-2-00033 13 13 50 255 272 290 373 428 574 611 621 644 836 955
period FR940104-2-00033 14 14 51 220 273 291 374 429 575 612 622 645 837 866 956
for FR940104-2-00033 21 15 52 92 141 218 277 307 393 430 464 482 515 547 623 780 867 874 921 939 946 1086
purposes FR940104-2-00033 1 16
patent FR940104-2-00033 19 18 97 182 200 214 414 505 511 520 533 544 548 561 599 845 852 868 875 884
extension FR940104-2-00033 9 19 94 282 382 846 869 876 886 947
; FR940104-2-00033 2 20 1097
betaseron FR940104-2-00033 8 21 53 470 478 516 581 624 781
Â® FR940104-2-00033 8 22 54 471 479 517 582 625 782
agency FR940104-2-00033 1 23
: FR940104-2-00033 12 24 33 37 106 145 176 298 666 691 762 813 1076
, FR940104-2-00033 62 29 87 91 122 127 131 135 137 149 157 162 166 168 171 236 240 243 246 267 311 395 418 503 530 556 557 597 633 646 683 685 692 697 698 714 724 725 763 768 769 792 803 814 829 849 877 901 905 906 926 933 937 938 962 981 984 987 990 994 1070 1077 1082
hhs FR940104-2-00033 1 30
action FR940104-2-00033 1 32
notice FR940104-2-00033 2 34 59
summary FR940104-2-00033 1 36
the FR940104-2-00033 76 38 48 71 75 81 93 115 177 195 229 259 275 279 312 317 321 325 332 337 342 350 362 378 384 397 413 423 439 466 493 504 526 532 543 560 578 584 592 598 607 618 638 642 652 663 669 680 694 700 702 719 734 739 741 749 757 765 771 773 807 809 819 834 839 850 864 894 909 944 953 963 1002 1017 1040 1047 1060
( FR940104-2-00033 20 43 119 154 188 204 232 392 451 454 457 472 518 676 707 777 783 913 975 1021 1028
fda FR940104-2-00033 16 44 68 257 357 419 461 538 558 605 614 715 731 793 816 932 972
) FR940104-2-00033 20 45 121 156 193 209 250 417 453 456 459 476 524 678 709 779 786 916 997 1024 1036
has FR940104-2-00033 4 46 69 615 817
determined FR940104-2-00033 2 47 616
is FR940104-2-00033 4 56 480 626 898
publishing FR940104-2-00033 1 57
this FR940104-2-00033 7 58 501 566 631 831 878 1050
that FR940104-2-00033 14 61 100 212 383 408 565 577 604 617 718 796 823 891 1030
as FR940104-2-00033 8 63 228 403 405 445 699 770 896
required FR940104-2-00033 1 64
by FR940104-2-00033 2 65 256
law FR940104-2-00033 1 66
made FR940104-2-00033 1 70
because FR940104-2-00033 1 73
submission FR940104-2-00033 2 76 344
an FR940104-2-00033 6 78 283 303 346 671 971
application FR940104-2-00033 8 79 347 514 706 742 776 810 873
to FR940104-2-00033 14 80 114 223 253 319 348 360 491 500 748 908 958 969 1016
commissioner FR940104-2-00033 3 82 385 1085
patents FR940104-2-00033 2 84 387
trademarks FR940104-2-00033 2 86 389
department FR940104-2-00033 1 88
commerce FR940104-2-00033 1 90
a FR940104-2-00033 16 96 213 219 268 288 299 368 371 426 431 510 553 572 844 922 940
which FR940104-2-00033 2 98 726
claims FR940104-2-00033 3 99 696 767
human FR940104-2-00033 8 101 233 308 351 432 467 567 750
biologic FR940104-2-00033 3 102 468 568
product FR940104-2-00033 13 103 235 239 269 353 364 434 469 569 593 608 752 774
addresses FR940104-2-00033 1 105
written FR940104-2-00033 2 107 917
comments FR940104-2-00033 4 108 918 1010 1053
petitions FR940104-2-00033 4 110 998 1012 1055
should FR940104-2-00033 3 111 999 1013
be FR940104-2-00033 6 112 216 401 1000 1014 1057
directed FR940104-2-00033 1 113
dockets FR940104-2-00033 4 116 910 1018 1061
management FR940104-2-00033 4 117 911 1019 1062
branch FR940104-2-00033 4 118 912 1020 1063
hfa305 FR940104-2-00033 1 120
rm FR940104-2-00033 1 128
123 FR940104-2-00033 1 130
12420 FR940104-2-00033 1 132
parklawn FR940104-2-00033 1 133
dr. FR940104-2-00033 1 134
rockville FR940104-2-00033 2 136 167
md FR940104-2-00033 2 138 169
20857 FR940104-2-00033 2 139 170
further FR940104-2-00033 1 142
information FR940104-2-00033 2 143 175
contact FR940104-2-00033 1 144
brian FR940104-2-00033 1 146
j. FR940104-2-00033 1 147
malkin FR940104-2-00033 1 148
office FR940104-2-00033 6 150 508 536 564 602 855
health FR940104-2-00033 3 152 759 1087
affairs FR940104-2-00033 2 153 1088
hfy20 FR940104-2-00033 1 155
5600 FR940104-2-00033 1 163
fishers FR940104-2-00033 1 164
lane FR940104-2-00033 1 165
3014431382 FR940104-2-00033 1 172
supplementary FR940104-2-00033 1 174
price FR940104-2-00033 1 179
competition FR940104-2-00033 1 180
term FR940104-2-00033 5 183 201 512 549 885
restoration FR940104-2-00033 4 184 202 513 550
act FR940104-2-00033 4 185 203 688 761
1984 FR940104-2-00033 2 187 995
pub FR940104-2-00033 2 189 205
l. FR940104-2-00033 2 191 207
98417 FR940104-2-00033 1 192
generic FR940104-2-00033 1 196
animal FR940104-2-00033 2 197 237
100670 FR940104-2-00033 1 208
generally FR940104-2-00033 1 210
provide FR940104-2-00033 1 211
may FR940104-2-00033 9 215 285 375 390 409 900 930 1032 1056
extended FR940104-2-00033 1 217
up FR940104-2-00033 1 222
5 FR940104-2-00033 1 224
years FR940104-2-00033 1 225
so FR940104-2-00033 1 226
long FR940104-2-00033 1 227
patented FR940104-2-00033 1 230
item FR940104-2-00033 2 231 260
medical FR940104-2-00033 1 241
device FR940104-2-00033 1 242
additive FR940104-2-00033 2 245 249
or FR940104-2-00033 4 247 589 903 935
color FR940104-2-00033 1 248
was FR940104-2-00033 10 251 261 415 723 727 743 787 799 811 826
subject FR940104-2-00033 1 252
before FR940104-2-00033 4 258 412 904 936
marketed FR940104-2-00033 1 262
under FR940104-2-00033 3 264 673 753
these FR940104-2-00033 2 265 656
acts FR940104-2-00033 1 266
's FR940104-2-00033 6 270 420 539 545 609 821
forms FR940104-2-00033 1 274
basis FR940104-2-00033 1 276
determining FR940104-2-00033 2 278 542
amount FR940104-2-00033 2 280 380
applicant FR940104-2-00033 6 284 695 766 820 879 945
receive FR940104-2-00033 1 286
consists FR940104-2-00033 1 292
two FR940104-2-00033 1 294
periods FR940104-2-00033 2 295 657
time FR940104-2-00033 4 297 407 632 659
testing FR940104-2-00033 5 300 313 398 440 639
phase FR940104-2-00033 10 301 305 314 334 339 399 441 444 640 654
approval FR940104-2-00033 7 304 333 338 443 502 579 653
products FR940104-2-00033 1 310
begins FR940104-2-00033 2 315 335
when FR940104-2-00033 1 316
exemption FR940104-2-00033 2 318 672
permit FR940104-2-00033 1 320
clinical FR940104-2-00033 2 322 496
investigations FR940104-2-00033 1 323
becomes FR940104-2-00033 1 327
effective FR940104-2-00033 4 328 690 711 721
runs FR940104-2-00033 1 330
until FR940104-2-00033 2 331 356
starts FR940104-2-00033 1 340
with FR940104-2-00033 6 341 487 746 889 949 1039
initial FR940104-2-00033 1 343
market FR940104-2-00033 2 349 361
continues FR940104-2-00033 1 355
grants FR940104-2-00033 1 358
permission FR940104-2-00033 1 359
although FR940104-2-00033 1 366
only FR940104-2-00033 1 367
portion FR940104-2-00033 1 369
count FR940104-2-00033 1 376
toward FR940104-2-00033 1 377
actual FR940104-2-00033 2 379 865
award FR940104-2-00033 1 391
example FR940104-2-00033 1 394
half FR940104-2-00033 1 396
must FR940104-2-00033 2 400 965
subtracted FR940104-2-00033 1 402
well FR940104-2-00033 1 404
any FR940104-2-00033 3 406 892 927
have FR940104-2-00033 1 410
occurred FR940104-2-00033 3 411 636 650
issued FR940104-2-00033 1 416
length FR940104-2-00033 2 424 842
will FR940104-2-00033 1 435
include FR940104-2-00033 1 436
all FR940104-2-00033 1 437
specified FR940104-2-00033 2 446 1004
in FR940104-2-00033 12 447 484 541 552 860 871 1001 1005 1025 1044 1046 1059
35 FR940104-2-00033 1 448
usc FR940104-2-00033 1 449
156 FR940104-2-00033 1 450
g FR940104-2-00033 1 452
1 FR940104-2-00033 3 455 667 983
b FR940104-2-00033 1 458
recently FR940104-2-00033 1 462
approved FR940104-2-00033 3 463 812 827
marketing FR940104-2-00033 2 465 588
interferon FR940104-2-00033 1 473
beta FR940104-2-00033 1 474
-1b FR940104-2-00033 1 475
indicated FR940104-2-00033 1 481
use FR940104-2-00033 2 483 590
ambulatory FR940104-2-00033 1 485
patients FR940104-2-00033 1 486
relapsingremitting FR940104-2-00033 1 488
multiple FR940104-2-00033 1 489
sclerosis FR940104-2-00033 1 490
reduce FR940104-2-00033 1 492
frequency FR940104-2-00033 1 494
exacerbations FR940104-2-00033 1 497
subsequent FR940104-2-00033 1 499
trademark FR940104-2-00033 5 507 535 563 601 854
received FR940104-2-00033 1 509
us FR940104-2-00033 2 519 851
4588585 FR940104-2-00033 1 523
from FR940104-2-00033 2 525 662
cetus FR940104-2-00033 1 527
oncology FR940104-2-00033 1 528
corp. FR940104-2-00033 1 529
requested FR940104-2-00033 2 537 603
assistance FR940104-2-00033 1 540
eligibility FR940104-2-00033 1 546
letter FR940104-2-00033 1 554
dated FR940104-2-00033 2 555 1075
advised FR940104-2-00033 1 559
had FR940104-2-00033 1 570
undergone FR940104-2-00033 1 571
represented FR940104-2-00033 1 583
first FR940104-2-00033 1 585
permitted FR940104-2-00033 1 586
commercial FR940104-2-00033 1 587
shortly FR940104-2-00033 1 595
thereafter FR940104-2-00033 1 596
determine FR940104-2-00033 1 606
applicable FR940104-2-00033 1 619
3720 FR940104-2-00033 1 627
days FR940104-2-00033 5 628 635 649 729 882
3319 FR940104-2-00033 1 634
during FR940104-2-00033 3 637 651 952
while FR940104-2-00033 1 647
401 FR940104-2-00033 1 648
were FR940104-2-00033 1 660
derived FR940104-2-00033 1 661
following FR940104-2-00033 1 664
dates FR940104-2-00033 2 665 895
date FR940104-2-00033 6 670 701 722 740 772 808
section FR940104-2-00033 2 674 754
505 FR940104-2-00033 1 675
i FR940104-2-00033 1 677
federal FR940104-2-00033 1 681
cosmetic FR940104-2-00033 1 687
became FR940104-2-00033 2 689 710
investigational FR940104-2-00033 1 703
new FR940104-2-00033 1 704
ind FR940104-2-00033 3 708 720 735
however FR940104-2-00033 3 713 791 848
records FR940104-2-00033 2 716 794
indicate FR940104-2-00033 2 717 795
30 FR940104-2-00033 1 728
after FR940104-2-00033 1 730
receipt FR940104-2-00033 1 732
2 FR940104-2-00033 1 737
initially FR940104-2-00033 3 744 788 800
submitted FR940104-2-00033 4 745 789 801 1015
respect FR940104-2-00033 1 747
351 FR940104-2-00033 1 755
public FR940104-2-00033 1 758
service FR940104-2-00033 1 760
license FR940104-2-00033 1 775
pla FR940104-2-00033 4 778 784 797 824
920495 FR940104-2-00033 3 785 798 825
on FR940104-2-00033 4 802 828 902 934
3 FR940104-2-00033 1 805
verified FR940104-2-00033 1 818
claim FR940104-2-00033 1 822
establishes FR940104-2-00033 1 838
maximum FR940104-2-00033 1 840
potential FR940104-2-00033 1 841
applies FR940104-2-00033 1 856
several FR940104-2-00033 1 857
statutory FR940104-2-00033 1 858
limitations FR940104-2-00033 1 859
its FR940104-2-00033 3 861 872 960
calculations FR940104-2-00033 1 862
seeks FR940104-2-00033 1 880
1500 FR940104-2-00033 1 881
anyone FR940104-2-00033 1 888
knowledge FR940104-2-00033 1 890
published FR940104-2-00033 1 897
incorrect FR940104-2-00033 1 899
submit FR940104-2-00033 2 907 1033
address FR940104-2-00033 2 914 1022
above FR940104-2-00033 2 915 1023
ask FR940104-2-00033 1 920
redetermination FR940104-2-00033 1 923
furthermore FR940104-2-00033 1 925
interested FR940104-2-00033 1 928
person FR940104-2-00033 1 929
petition FR940104-2-00033 2 931 964
regarding FR940104-2-00033 1 942
whether FR940104-2-00033 1 943
acted FR940104-2-00033 1 948
due FR940104-2-00033 1 950
diligence FR940104-2-00033 1 951
meet FR940104-2-00033 1 959
burden FR940104-2-00033 1 961
contain FR940104-2-00033 1 966
sufficient FR940104-2-00033 1 967
facts FR940104-2-00033 1 968
merit FR940104-2-00033 1 970
investigation FR940104-2-00033 1 973
see FR940104-2-00033 1 976
h. FR940104-2-00033 1 977
rept FR940104-2-00033 1 978
857 FR940104-2-00033 1 980
part FR940104-2-00033 1 982
98th FR940104-2-00033 1 985
cong. FR940104-2-00033 1 986
2d FR940104-2-00033 1 988
sess. FR940104-2-00033 1 989
pp FR940104-2-00033 1 991
4142 FR940104-2-00033 1 993
format FR940104-2-00033 1 1003
21 FR940104-2-00033 1 1006
cfr FR940104-2-00033 1 1007
10.30 FR940104-2-00033 1 1008
three FR940104-2-00033 1 1026
copies FR940104-2-00033 2 1027 1035
except FR940104-2-00033 1 1029
individuals FR940104-2-00033 1 1031
single FR940104-2-00033 1 1034
identified FR940104-2-00033 1 1038
number FR940104-2-00033 1 1042
found FR940104-2-00033 1 1043
brackets FR940104-2-00033 1 1045
heading FR940104-2-00033 1 1048
document FR940104-2-00033 1 1051
seen FR940104-2-00033 1 1058
between FR940104-2-00033 1 1064
9 FR940104-2-00033 1 1065
am FR940104-2-00033 2 1066 1099
4 FR940104-2-00033 1 1068
pm FR940104-2-00033 1 1069
monday FR940104-2-00033 1 1071
through FR940104-2-00033 1 1072
friday FR940104-2-00033 1 1073
allen FR940104-2-00033 1 1079
b. FR940104-2-00033 1 1080
duncan FR940104-2-00033 1 1081
acting FR940104-2-00033 1 1083
associate FR940104-2-00033 1 1084
fr FR940104-2-00033 1 1091
doc FR940104-2-00033 1 1092
9436 FR940104-2-00033 1 1094
filed FR940104-2-00033 1 1095
1394 FR940104-2-00033 1 1096
8:45 FR940104-2-00033 1 1098
billing FR940104-2-00033 1 1101
code FR940104-2-00033 1 1102
416001f FR940104-2-00033 1 1103
[ FR940104-2-00034 2 0 1122
docket FR940104-2-00034 2 1 917
no FR940104-2-00034 9 2 13 50 130 191 606 801 885 1042
. FR940104-2-00034 38 3 14 24 28 51 72 77 87 118 131 141 176 192 220 233 245 282 299 422 525 619 656 706 745 785 824 838 867 886 901 943 980 1043 1073 1104 1108 1121 1125
93n0416 FR940104-2-00034 1 4
] FR940104-2-00034 2 5 1132
avre FR940104-2-00034 26 6 60 64 73 96 201 225 243 252 460 478 484 506 576 588 604 645 667 730 750 776 799 823 847 895 1056
inc. FR940104-2-00034 4 7 61 202 1057
; FR940104-2-00034 5 8 356 390 504 1129
revocation FR940104-2-00034 7 9 42 86 122 183 232 877
of FR940104-2-00034 30 10 43 69 123 184 217 242 251 371 414 441 464 542 554 565 593 662 671 698 729 822 878 894 906 925 990 1009 1055 1062 1091
us FR940104-2-00034 7 11 48 128 189 771 883 1040
license FR940104-2-00034 23 12 46 49 57 126 129 137 187 190 198 226 274 298 680 732 772 881 884 893 911 1038 1041 1049
1074003 FR940104-2-00034 7 15 52 132 193 773 887 1044
agency FR940104-2-00034 1 16
: FR940104-2-00034 8 17 26 30 120 146 179 312 1106
food FR940104-2-00034 5 18 32 161 937 1010
and FR940104-2-00034 35 19 33 54 101 110 134 155 162 195 293 391 439 443 505 534 552 603 627 681 696 702 859 889 938 973 987 1002 1011 1018 1028 1046 1078 1084 1097 1119
drug FR940104-2-00034 4 20 34 163 939
administration FR940104-2-00034 4 21 35 164 940
, FR940104-2-00034 68 22 62 94 95 140 150 160 165 169 171 174 203 208 210 213 258 263 303 309 338 354 378 434 436 438 457 483 494 499 531 533 549 551 573 587 602 624 626 638 644 693 695 724 733 752 753 760 795 845 846 872 873 936 941 945 949 951 976 982 1001 1023 1035 1058 1067 1071 1107 1112 1114
hhs FR940104-2-00034 1 23
action FR940104-2-00034 1 25
notice FR940104-2-00034 3 27 762 1075
summary FR940104-2-00034 1 29
the FR940104-2-00034 65 31 41 44 55 67 79 105 121 124 135 182 185 196 215 224 234 239 248 269 273 278 283 289 297 310 432 473 540 547 555 585 590 599 649 660 663 675 679 682 690 699 707 756 796 811 820 825 854 879 890 897 910 916 923 929 962 991 1007 1021 1036 1047 1052 1060 1089 1092
( FR940104-2-00034 25 36 47 63 127 157 188 322 330 334 419 449 453 568 630 634 782 792 882 933 966 996 1013 1030 1039 1099
fda FR940104-2-00034 12 37 92 180 246 264 657 754 764 814 843 874 902
) FR940104-2-00034 25 38 53 65 133 159 194 325 336 337 421 455 456 572 636 637 784 794 888 935 969 1000 1017 1034 1045 1103
is FR940104-2-00034 3 39 82 1076
announcing FR940104-2-00034 1 40
establishment FR940104-2-00034 6 45 100 125 186 880 1037
product FR940104-2-00034 7 56 102 136 197 701 892 1048
issued FR940104-2-00034 5 58 199 774 1050 1077
to FR940104-2-00034 32 59 91 200 308 315 345 361 384 395 425 528 560 579 584 622 647 688 717 749 766 769 775 778 807 818 831 842 909 1006 1020 1051 1088
for FR940104-2-00034 21 66 115 142 152 214 238 326 406 431 446 489 614 674 835 853 864 958 1025 1059 1094 1116
manufacture FR940104-2-00034 3 68 216 1061
source FR940104-2-00034 5 70 218 347 363 1063
plasma FR940104-2-00034 7 71 219 348 364 465 480 1064
has FR940104-2-00034 2 74 903
several FR940104-2-00034 1 75
locations FR940104-2-00034 2 76 222
only FR940104-2-00034 3 78 244 900
tacoma FR940104-2-00034 8 80 106 209 240 249 855 898 1053
location FR940104-2-00034 7 81 107 241 250 856 899 1054
affected FR940104-2-00034 2 83 229
by FR940104-2-00034 3 84 230 477
this FR940104-2-00034 4 85 231 926 1074
in FR940104-2-00034 22 88 272 296 339 458 546 574 598 609 639 678 715 727 741 746 786 839 868 920 922 928 961
a FR940104-2-00034 18 89 116 353 368 377 385 400 412 520 562 635 669 718 747 836 840 865 869
letter FR940104-2-00034 6 90 748 797 826 841 870
dated FR940104-2-00034 5 93 751 844 871 1105
requested FR940104-2-00034 2 97 849
that FR940104-2-00034 15 98 261 340 459 471 537 575 640 659 685 703 711 763 800 850
its FR940104-2-00034 7 99 113 510 610 829 851 862
licenses FR940104-2-00034 4 103 235 821 852
at FR940104-2-00034 7 104 467 490 594 615 666 896
be FR940104-2-00034 3 108 805 857
revoked FR940104-2-00034 4 109 237 858 1066
thereby FR940104-2-00034 2 111 860
waived FR940104-2-00034 2 112 861
opportunity FR940104-2-00034 3 114 834 863
hearing FR940104-2-00034 3 117 837 866
dates FR940104-2-00034 1 119
became FR940104-2-00034 1 138
effective FR940104-2-00034 3 139 740 1068
further FR940104-2-00034 3 143 447 827
information FR940104-2-00034 3 144 178 393
contact FR940104-2-00034 1 145
jean FR940104-2-00034 1 147
m. FR940104-2-00034 1 148
olson FR940104-2-00034 1 149
center FR940104-2-00034 4 151 1024 1093 1115
biologics FR940104-2-00034 4 153 1026 1095 1117
evaluation FR940104-2-00034 4 154 1027 1096 1118
research FR940104-2-00034 4 156 1029 1098 1120
hfm635 FR940104-2-00034 1 158
1401 FR940104-2-00034 1 166
rockville FR940104-2-00034 3 167 170 950
pike FR940104-2-00034 1 168
md FR940104-2-00034 2 172 952
208521448 FR940104-2-00034 1 173
3015943074 FR940104-2-00034 1 175
supplementary FR940104-2-00034 1 177
announces FR940104-2-00034 1 181
10506 FR940104-2-00034 1 204
bridgeport FR940104-2-00034 1 205
way FR940104-2-00034 1 206
sw. FR940104-2-00034 1 207
wa FR940104-2-00034 1 211
98499 FR940104-2-00034 1 212
other FR940104-2-00034 1 221
under FR940104-2-00034 6 223 915 983 1003 1080 1085
are FR940104-2-00034 3 227 686 956
not FR940104-2-00034 7 228 306 398 501 508 735 739
were FR940104-2-00034 7 236 305 343 359 734 738 1065
inspected FR940104-2-00034 1 247
on FR940104-2-00034 3 253 652 913
april FR940104-2-00034 2 254 721
7 FR940104-2-00034 1 255
through FR940104-2-00034 3 256 720 978
21 FR940104-2-00034 12 257 331 450 569 631 779 789 984 1014 1031 1081 1100
1993. FR940104-2-00034 1 259
during FR940104-2-00034 3 260 352 641
inspection FR940104-2-00034 4 262 284 709 723
observed FR940104-2-00034 1 265
numerous FR940104-2-00034 1 266
deviations FR940104-2-00034 3 267 287 301
from FR940104-2-00034 3 268 288 466
standards FR940104-2-00034 3 270 294 676
established FR940104-2-00034 3 271 295 677
as FR940104-2-00034 4 275 277 411 559
well FR940104-2-00034 1 276
applicable FR940104-2-00034 2 279 290
federal FR940104-2-00034 3 280 291 683
regulations FR940104-2-00034 4 281 292 684 812
documented FR940104-2-00034 1 285
serious FR940104-2-00034 1 286
these FR940104-2-00034 2 300 954
included FR940104-2-00034 1 302
but FR940104-2-00034 1 304
limited FR940104-2-00034 1 307
following FR940104-2-00034 1 311
1. FR940104-2-00034 1 313
failure FR940104-2-00034 4 314 424 527 621
follow FR940104-2-00034 2 316 426
adequate FR940104-2-00034 2 317 427
written FR940104-2-00034 2 318 428
standard FR940104-2-00034 1 319
operating FR940104-2-00034 1 320
procedures FR940104-2-00034 1 321
sop FR940104-2-00034 2 323 429
's FR940104-2-00034 5 324 430 479 485 731
determining FR940104-2-00034 1 327
donor FR940104-2-00034 5 328 486 517 597 611
suitability FR940104-2-00034 1 329
cfr FR940104-2-00034 11 332 451 570 632 780 790 985 1015 1032 1082 1101
606.100 FR940104-2-00034 2 333 452
b FR940104-2-00034 4 335 454 783 793
four FR940104-2-00034 2 341 653
donors FR940104-2-00034 6 342 358 396 470 493 586
allowed FR940104-2-00034 3 344 360 476
donate FR940104-2-00034 2 346 362
more FR940104-2-00034 2 349 407
than FR940104-2-00034 4 350 373 403 408
twice FR940104-2-00034 1 351
period FR940104-2-00034 2 355 379
five FR940104-2-00034 1 357
who FR940104-2-00034 2 365 518
had FR940104-2-00034 2 366 605
experienced FR940104-2-00034 1 367
weight FR940104-2-00034 1 369
loss FR940104-2-00034 1 370
greater FR940104-2-00034 2 372 402
10 FR940104-2-00034 2 374 409
pounds FR940104-2-00034 1 375
within FR940104-2-00034 1 376
without FR940104-2-00034 1 380
first FR940104-2-00034 1 381
being FR940104-2-00034 1 382
referred FR940104-2-00034 1 383
physician FR940104-2-00034 4 386 388 511 513
or FR940104-2-00034 3 387 512 737
substitute FR940104-2-00034 2 389 514
educational FR940104-2-00034 1 392
provided FR940104-2-00034 3 394 761 806
did FR940104-2-00034 3 397 500 507
reference FR940104-2-00034 1 399
temperature FR940104-2-00034 2 401 521
100.5 FR940104-2-00034 1 404
f FR940104-2-00034 2 405 524
days FR940104-2-00034 1 410
symptom FR940104-2-00034 1 413
acquired FR940104-2-00034 1 415
immune FR940104-2-00034 1 416
deficiency FR940104-2-00034 1 417
syndrome FR940104-2-00034 1 418
aids FR940104-2-00034 1 420
2. FR940104-2-00034 1 423
collection FR940104-2-00034 2 433 548
processing FR940104-2-00034 2 435 550
storage FR940104-2-00034 2 437 553
distribution FR940104-2-00034 1 440
blood FR940104-2-00034 3 442 444 556
components FR940104-2-00034 1 445
manufacturing FR940104-2-00034 1 448
collected FR940104-2-00034 1 461
an FR940104-2-00034 2 462 833
amount FR940104-2-00034 1 463
least FR940104-2-00034 4 468 491 595 616
three FR940104-2-00034 1 469
exceeded FR940104-2-00034 1 472
maximum FR940104-2-00034 1 474
volume FR940104-2-00034 2 475 481
nomogram FR940104-2-00034 1 482
record FR940104-2-00034 2 487 612
files FR940104-2-00034 1 488
20 FR940104-2-00034 1 492
6 FR940104-2-00034 1 495
with FR940104-2-00034 3 496 788 810
multiple FR940104-2-00034 1 497
donations FR940104-2-00034 1 498
contain FR940104-2-00034 1 502
photographs FR940104-2-00034 1 503
have FR940104-2-00034 1 509
evaluate FR940104-2-00034 1 515
one FR940104-2-00034 3 516 596 617
exhibited FR940104-2-00034 1 519
below FR940104-2-00034 1 522
97 FR940104-2-00034 1 523
3. FR940104-2-00034 1 526
maintain FR940104-2-00034 1 529
complete FR940104-2-00034 2 530 563
accurate FR940104-2-00034 1 532
concurrent FR940104-2-00034 1 535
records FR940104-2-00034 1 536
clearly FR940104-2-00034 1 538
traced FR940104-2-00034 1 539
steps FR940104-2-00034 1 541
each FR940104-2-00034 1 543
significant FR940104-2-00034 1 544
procedure FR940104-2-00034 1 545
products FR940104-2-00034 1 557
so FR940104-2-00034 1 558
provide FR940104-2-00034 1 561
history FR940104-2-00034 1 564
work FR940104-2-00034 1 566
performed FR940104-2-00034 1 567
606.160 FR940104-2-00034 1 571
was FR940104-2-00034 1 577
unable FR940104-2-00034 1 578
trace FR940104-2-00034 1 580
two FR940104-2-00034 1 581
unit FR940104-2-00034 2 582 607
numbers FR940104-2-00034 1 583
misspelled FR940104-2-00034 1 589
last FR940104-2-00034 1 591
name FR940104-2-00034 1 592
deferral FR940104-2-00034 1 600
file FR940104-2-00034 3 601 613 914
number FR940104-2-00034 2 608 918
donation FR940104-2-00034 1 618
4. FR940104-2-00034 1 620
observe FR940104-2-00034 1 623
standardize FR940104-2-00034 1 625
calibrate FR940104-2-00034 1 628
equipment FR940104-2-00034 1 629
606.60 FR940104-2-00034 1 633
october FR940104-2-00034 1 642
1992 FR940104-2-00034 2 643 722
failed FR940104-2-00034 1 646
clean FR940104-2-00034 1 648
air FR940104-2-00034 1 650
filters FR940104-2-00034 1 651
autopheresisc FR940104-2-00034 1 654
machines FR940104-2-00034 1 655
determined FR940104-2-00034 1 658
nature FR940104-2-00034 1 661
deficiencies FR940104-2-00034 1 664
found FR940104-2-00034 2 665 919
showed FR940104-2-00034 2 668 710
pattern FR940104-2-00034 1 670
careless FR940104-2-00034 1 672
disregard FR940104-2-00034 1 673
designed FR940104-2-00034 1 687
ensure FR940104-2-00034 1 689
continued FR940104-2-00034 1 691
safety FR940104-2-00034 1 692
purity FR940104-2-00034 1 694
potency FR940104-2-00034 1 697
manufactured FR940104-2-00034 1 700
willfulness FR940104-2-00034 1 704
existed FR940104-2-00034 1 705
recent FR940104-2-00034 1 708
corrective FR940104-2-00034 1 712
actions FR940104-2-00034 1 713
promised FR940104-2-00034 1 714
response FR940104-2-00034 1 716
march FR940104-2-00034 1 719
which FR940104-2-00034 1 725
resulted FR940104-2-00034 1 726
suspension FR940104-2-00034 1 728
implemented FR940104-2-00034 1 736
achieving FR940104-2-00034 1 742
longterm FR940104-2-00034 1 743
compliance FR940104-2-00034 2 744 809
delineated FR940104-2-00034 1 755
observations FR940104-2-00034 1 757
listed FR940104-2-00034 1 758
above FR940104-2-00034 2 759 968
intended FR940104-2-00034 1 765
institute FR940104-2-00034 2 767 816
proceedings FR940104-2-00034 2 768 817
revoke FR940104-2-00034 2 770 819
pursuant FR940104-2-00034 1 777
601.5 FR940104-2-00034 3 781 791 986
accordance FR940104-2-00034 1 787
advised FR940104-2-00034 1 798
additional FR940104-2-00034 1 802
time FR940104-2-00034 1 803
would FR940104-2-00034 2 804 815
achieve FR940104-2-00034 1 808
before FR940104-2-00034 1 813
announced FR940104-2-00034 1 828
intent FR940104-2-00034 1 830
offer FR940104-2-00034 1 832
voluntarily FR940104-2-00034 1 848
acknowledged FR940104-2-00034 1 875
voluntary FR940104-2-00034 1 876
aforementioned FR940104-2-00034 1 891
placed FR940104-2-00034 1 904
copies FR940104-2-00034 1 905
letters FR940104-2-00034 1 907
relevant FR940104-2-00034 1 908
revocations FR940104-2-00034 1 912
brackets FR940104-2-00034 1 921
heading FR940104-2-00034 1 924
document FR940104-2-00034 1 927
dockets FR940104-2-00034 2 930 963
management FR940104-2-00034 2 931 964
branch FR940104-2-00034 2 932 965
hfa305 FR940104-2-00034 1 934
rm FR940104-2-00034 1 942
123 FR940104-2-00034 1 944
12420 FR940104-2-00034 1 946
parklawn FR940104-2-00034 1 947
dr. FR940104-2-00034 1 948
20857. FR940104-2-00034 1 953
documents FR940104-2-00034 1 955
available FR940104-2-00034 1 957
public FR940104-2-00034 2 959 992
examination FR940104-2-00034 1 960
address FR940104-2-00034 1 967
between FR940104-2-00034 1 970
9 FR940104-2-00034 1 971
am FR940104-2-00034 2 972 1131
4 FR940104-2-00034 1 974
pm FR940104-2-00034 1 975
monday FR940104-2-00034 1 977
friday FR940104-2-00034 1 979
accordingly FR940104-2-00034 1 981
section FR940104-2-00034 1 988
351 FR940104-2-00034 1 989
health FR940104-2-00034 1 993
service FR940104-2-00034 1 994
act FR940104-2-00034 1 995
42 FR940104-2-00034 1 997
usc FR940104-2-00034 1 998
262 FR940104-2-00034 1 999
authority FR940104-2-00034 2 1004 1086
delegated FR940104-2-00034 2 1005 1087
commissioner FR940104-2-00034 1 1008
drugs FR940104-2-00034 1 1012
5.10 FR940104-2-00034 1 1016
redelegated FR940104-2-00034 1 1019
director FR940104-2-00034 3 1022 1090 1113
5.68 FR940104-2-00034 1 1033
november FR940104-2-00034 1 1069
8 FR940104-2-00034 1 1070
1993 FR940104-2-00034 1 1072
published FR940104-2-00034 1 1079
601.8 FR940104-2-00034 1 1083
5.67 FR940104-2-00034 1 1102
kathryn FR940104-2-00034 1 1109
c. FR940104-2-00034 1 1110
zoon FR940104-2-00034 1 1111
fr FR940104-2-00034 1 1123
doc FR940104-2-00034 1 1124
9437 FR940104-2-00034 1 1126
filed FR940104-2-00034 1 1127
1394 FR940104-2-00034 1 1128
8:45 FR940104-2-00034 1 1130
billing FR940104-2-00034 1 1133
code FR940104-2-00034 1 1134
416001f FR940104-2-00034 1 1135
[ FR940104-2-00035 1 0
docket FR940104-2-00035 1 1
no FR940104-2-00035 1 2
. FR940104-2-00035 2 3 24
93f0112 FR940104-2-00035 1 4
] FR940104-2-00035 1 5
milliken FR940104-2-00035 1 6
chemical FR940104-2-00035 1 7
; FR940104-2-00035 2 8 14
filing FR940104-2-00035 1 9
of FR940104-2-00035 1 10
food FR940104-2-00035 2 11 18
additive FR940104-2-00035 1 12
petition FR940104-2-00035 1 13
amendment FR940104-2-00035 1 15
agency FR940104-2-00035 1 16
: FR940104-2-00035 1 17
and FR940104-2-00035 1 19
drug FR940104-2-00035 1 20
administration FR940104-2-00035 1 21
, FR940104-2-00035 1 22
hhs FR940104-2-00035 1 23
action FR940104-2-00035 1 25
